+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ex vivo expansion of umbilical cord blood cells generated from CD34+ progenitors by using a megakaryocyte-active cytokine combination



Ex vivo expansion of umbilical cord blood cells generated from CD34+ progenitors by using a megakaryocyte-active cytokine combination



Infusion Therapy & Transfusion Medicine 28(6): 318-325



Background: The combination of IL-1, IL-6, IL-11, stem cell factor (SCF), and thrombopoietin (TPO) is capable of stimulating megakaryocytopoiesis using a bone marrow CD34+ cell population in a 10- to 12-day expansion culture. We evaluated the ex vivo effect of these cytokines in combination with flt-3 ligand (FL) in expanding CD34+ umbilical cord blood (UCB) cells. Material and Methods: To investigate the developmental kinetics of cell expansion, CD34+ cells were selected from 19 UCB units and cultured for 5-21 days in 24-well plates in serum-containing medium (1X104 cells/ml). Cytokines included IL-1 (10 ng/ml), IL-6, IL-11, and SCF (each 25 ng/ml) as a basic cocktail with the addition of either TPO (50 ng/ml) or FL (50 ng/ml) or both TPO and FL. CD34 and CD41 antibodies were used to identify progenitors and megacaryocytic (MK) cells by flow cytometry, and CFU-MK assay was performed to quantify MK progenitors. Results: The medium containing TPO plus FL provided the best stimulus for developing MK cells and resulted in a significant expansion of CD41+ cells from day 5 to day 11, with a mean increase of up to 123-fold (14- to 284-fold) in contrast to 78-fold expansion of total nucleated cells (NC) (12- to 150-fold, p<0.01, n=8). The percentage of CD34+ cells showed a significant decrease from 83% to less than 1%, as well as the relative concentration of MK progenitor cells which dropped from a mean of 128 per 104 CD34+ cells to 10-70 at day 5. However, because of NC amplification, a slight expansion in CFU-MK could be observed showing a 7.8-fold increase using all six cytokines over 8 days. Conclusion: UCB CD34+ cell expansion over 14 days by using the above-mentioned cytokine combinations induces a strong maturation pressure and causes the progenitors to undergo MK differentiation. Finally, it results in only a slight expansion of MK progenitor cells measured by the CFU-MK assay.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010627950

Download citation: RISBibTeXText


Related references

Ex vivo expansion of megakaryocyte progenitors from human umbilical cord blood CD34(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(5): 1121-1125, 2008

Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture. CytoTherapy 13(4): 467-480, 2011

Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34+ cells in a closed system. Pediatric Research 51(4 Part 2): 245A, 2002

Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biology of Blood and Marrow Transplantation 9(3): 151-156, 2003

Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(6): 1398-1402, 2008

Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Blood Cells 20(2-3): 436-454, 1994

Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood progenitors is greatly enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Blood 82(10 Suppl. 1): 16A, 1993

Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion. Stem Cells 21(2): 228-235, 2003

Human mesenchymal stem cells enhance ex vivo expansion of human megakaryocyte, erythroid and myeloid progenitors from purified cord blood CD34+ cells. Blood 92(10 Suppl. 1 Part 1-2): 725A, 1998

Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood: A potential source of megakaryocytes for transplantation. Experimental Hematology (Charlottesville) 30(9): 1079-1087, 2002

Different cytokine requirements for optimal ex vivo expansion of CD34+ hematopoietic cells from umbilical cord blood and bone marrow. Blood 94(10 Suppl. 1 Part 2): 349b, 1999

Optimizing megakaryocyte precursor expansion of umbilical cord blood CD34+ cells. Blood 94(10 Suppl. 1 Part 2): 350b, 1999

Preclinical ex-vivo expansion of human megakaryocyte progenitors from umbilical cord blood for transplantation using a new two-step separation procedure. Blood 92(10 Suppl. 1 Part 1-2): 310B, 1998